We are live on ! Find out more
CCM

Cullen Capital Management Portfolio holdings

AUM $9.75B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$3.85B
AUM Growth
+$155M
Cap. Flow
-$23.5M
Cap. Flow %
-0.61%
Top 10 Hldgs %
32.64%
Holding
238
New
38
Increased
42
Reduced
43
Closed
30

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$69.4M
2
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$29.5M
3
JPM icon
JPMorgan Chase
JPM
+$4.17M
4
MET icon
MetLife
MET
+$4.11M
5
GE icon
GE Aerospace
GE
+$4.1M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$66M
2
AZN icon
AstraZeneca
AZN
+$56.1M
3
EQNR icon
Equinor
EQNR
+$26.1M
4
MMM icon
3M
MMM
+$6.47M
5
MO icon
Altria Group
MO
+$6.38M

Sector Composition

Rank Sector Weight
1 Healthcare 13.67%
2 Energy 12.43%
3 Financials 10.98%
4 Technology 10.92%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DO
26
DELISTED
Diamond Offshore Drilling
DO
$74.2M 1.93%
1,494,270
+4,620
+0.3% +$230K
PFE icon
27
Pfizer
PFE
$143B
$68.6M 1.78%
+2,436,353
New +$69.4M
GPC icon
28
Genuine Parts
GPC
$17.9B
$66.8M 1.73%
760,340
– –
DEO icon
29
Diageo
DEO
$49.6B
$65.5M 1.7%
514,310
– –
DOC icon
30
Healthpeak Properties
DOC
$15.5B
$62.5M 1.62%
1,657,881
– –
VOD icon
31
Vodafone
VOD
$37.1B
$60.1M 1.56%
1,799,618
-36,363
-2% -$1.29M
AZN icon
32
AstraZeneca
AZN
$269B
$57.6M 1.5%
774,950
-775,950
-50% -$56.1M
BA icon
33
Boeing
BA
$169B
$31.6M 0.82%
248,300
-2,250
-0.9% -$294K
GLW icon
34
Corning
GLW
$107B
$24.4M 0.63%
1,113,515
– –
SJR
35
DELISTED
Shaw Communications Inc.
SJR
$23.3M 0.61%
909,250
– –
GEN icon
36
Gen Digital
GEN
$16.5B
$20.4M 0.53%
889,986
+5,570
+0.6% +$118K
NVS icon
37
Novartis
NVS
$302B
$15.8M 0.41%
195,300
-19,474
-9% -$1.53M
TTE icon
38
TotalEnergies
TTE
$193B
$14.4M 0.37%
199,750
-18,800
-9% -$1.32M
MFC icon
39
Manulife Financial
MFC
$73B
$10.5M 0.27%
530,300
-86,500
-14% -$1.63M
BTI icon
40
British American Tobacco
BTI
$136B
$8.87M 0.23%
148,900
-27,200
-15% -$1.59M
NADL
41
DELISTED
North Atlantic Drilling Ltd
NADL
$7.83M 0.2%
73,770
+2,360
+3% +$222K
ABB
42
DELISTED
ABB Ltd
ABB
$5.47M 0.14%
237,580
-52,100
-18% -$1.26M
IBN icon
43
ICICI Bank
IBN
$107B
$2.24M 0.06%
247,225
-31,625
-11% -$272K
TEVA icon
44
Teva Pharmaceuticals
TEVA
$40.4B
$2.17M 0.06%
41,500
+5,950
+17% +$304K
TSM icon
45
TSMC
TSM
$1.94T
$2.17M 0.06%
101,300
-17,730
-15% -$365K
CEO
46
DELISTED
CNOOC Limited
CEO
$1.77M 0.05%
+9,900
New +$1.68M
KDP icon
47
Keurig Dr Pepper
KDP
$42.8B
$1.56M 0.04%
26,600
– –
ESLT icon
48
Elbit Systems
ESLT
$36B
$1.55M 0.04%
25,139
-61
-0.2% -$3.74K
PBR.A icon
49
Petrobras Class A
PBR.A
$106B
$1.53M 0.04%
+98,000
New +$1.51M
LXFR icon
50
Luxfer Holdings
LXFR
$456M
$1.5M 0.04%
79,050
+65,000
+463% +$1.25M
1
2
3 4 5

Similar funds

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Cullen Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cullen Capital Management held 238 positions worth $3.85B, up 4.2% from $3.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cullen Capital Management's Q2 2014 filing shows 38 new, 42 increased, 43 reduced and 30 closed positions. Its largest new stake was Pfizer: 2,436,353 shares worth $68.6M. The largest sale was Dominion Energy, an estimated $66M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Energy and Financials.

  • Cullen Capital Management's largest Q2 2014 buy was Pfizer: 2,436,353 shares worth $68.6M.
  • Cullen Capital Management added most to Royal Dutch Shell PLC ADS Class B in Q2 2014, an estimated $29.5M increase.
  • Cullen Capital Management's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $56.1M.
  • Cullen Capital Management fully exited Dominion Energy in Q2 2014, selling an estimated $66M.
  • Cullen Capital Management's ten largest holdings make up 33% of its $3.85B portfolio in Q2 2014.
  • Cullen Capital Management opened 38 new positions and closed 30 in Q2 2014.
  • Cullen Capital Management's portfolio value rose 4.2% quarter-over-quarter to $3.85B.

Based on Cullen Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.